🌿 Village Green
Friday, May 16, 2026 | 7:30 AM ET | Curated by Sheeba
Curated from social media posts and threads across Twitter/X, Reddit, and LinkedIn
Vireo Growth Dominates May M&A: Four Deals Close, Fifth Announced
Vireo Growth closes four transactions in six weeks, building footprint of 160+ dispensaries across 10 states. Strategic consolidation positions MSO as major player ahead of federal rescheduling.
Cannabist Files Chapter 15: Once-Marquee MSO Exits Multiple Markets
Cannabist bankruptcy filing accelerates market consolidation. Company selling Ohio and Delaware permits for $63.5M combined; Virginia exit closed in February for $130M. Signals MSO weakness amid rescheduling transition.
High Tide’s Remexian Wins Dual Court Victories in German Market
High Tide’s recently acquired German subsidiary, Remexian Pharma, secures court wins against competitors in thriving German medical cannabis market. €27.2M investment paying dividends in international expansion strategy.
DEA Schedules Marijuana Rescheduling Hearing for June 29, 2026
Justice Department announces new administrative hearing starting June 29 to resolve marijuana rescheduling. Federal Register notice published to govern proceedings. Major regulatory milestone on horizon.
DOJ Rescheduling Order: Limited Medical Cannabis Relief, Not Full Legalization
Trump administration’s partial rescheduling eases specific regulatory burdens for medical cannabis but leaves broader legal framework unchanged. State-legal industry remains non-compliant federally despite easing pressure.
Congress Fractures Over Rescheduling: Republicans Attempt to Block
GOP Senator Jim Banks urges Indiana Governor not to legalize despite federal rescheduling. Congressional report details limitations of rescheduling. Federal-state policy tension continues even as rescheduling proceeds.
Georgia Governor Expands Medical Marijuana Access: Vaping Permitted, New Conditions
Georgia’s executive action adds vaping as delivery method, expands qualifying conditions, and changes THC potency limits. State-level expansion continues despite federal rescheduling debate. Growing medical market opportunity.
ATF Updates Gun Form to Recognize Medical Marijuana’s Legal Status
Federal agency adjusts form acknowledging medical marijuana’s federally legal status under Trump rescheduling. Administrative harmonization signals regulatory acceptance of partial rescheduling framework.
California Study: Cannabis Shows Potential for Obesity & Diabetes Treatment
New research from California finds evidence cannabis could treat obesity and diabetes. Broadens therapeutic use case beyond traditional pain/anxiety indications. Potential catalyst for medical cannabis expansion.
Congress Presses Trump for Complete Reform Beyond Rescheduling
Members of Congress and activists highlight need for comprehensive marijuana policy reform beyond incremental rescheduling. Message: partial measures insufficient to resolve federal-state conflict. Pressure building for full legalization.
France CBD Edibles Ban Takes Effect May 15: Regulatory Crackdown
France implements sweeping CBD edibles ban effective May 15, 2026. European regulatory crackdown signals tightening restrictions on hemp-derived cannabinoid products across international markets.
Switzerland’s Lausanne Pilot: Legal Market Cuts Consumption 20%, Impacts Black Market
Cann-L pilot project in Lausanne shows 20% consumption reduction and significant black market revenue loss. Evidence-based framework suggests regulated legal markets protect youth while reducing illicit competition.
📰 Village Green | Daily Cannabis Industry Intelligence
Curated by Sheeba | Weedstock.com